ASK REDCHAT ANYTHING ABOUT ELEDON PHARMACEUTICALS INC.
Eledon Pharmaceuticals Inc. (NASDAQ: ELDN)
Listen to this Section
$3.42
-0.1800
(
-5.00% )
343.4K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| Tegoprubart (AT-1501)DetailsType 1 diabetes, Islet Cell Transplantation |
Phase 2 |
| Tegoprubart (AT-1501)DetailsRenal Transplantation |
Phase 2 |
| Tegoprubart (AT-1501)DetailsAmyotrophic lateral sclerosis |
Phase 2 |
| Tegoprubart (AT-1501)DetailsAutoimmune nephritis |
Failed |
| Tegoprubart (AT-1501)DetailsIgA nephropathy |
Failed |
Market Data
|
| Open |
$3.42 |
| Previous Close |
$3.60 |
| Volume |
343.4K |
| Market Cap |
$269.39M |
| Day Range |
$3.42 - $3.73 |
| 52 Week Range |
$1.35 - $4.60 |
| Shares Outstanding |
77.19M |
| Change % |
-5.00% |
| Net Change |
▼ -0.1800 |
| Insider Ownership |
-0.17% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2014 |
| Country | United States |
Insider Ownership Transactions
Total Amount Purchased:
1,489,605.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2024-10-31 |
Buy |
2213816.00 |
BVF PARTNERS L P/IL |
| 2024-06-14 |
Sale |
-241650.00 |
Smith Bryan E. |
| 2024-06-14 |
Sale |
-428148.00 |
Perrin Steven |
| 2024-06-14 |
Sale |
-267470.00 |
Little Paul Sean |
| 2024-06-14 |
Sale |
-517454.00 |
Gros David-Alexandre C |
| 2024-05-13 |
Buy |
1031385.00 |
BVF PARTNERS L P/IL |
| 2023-10-03 |
Sale |
-150437.00 |
Kirk Allan |
| 2023-10-03 |
Sale |
-150437.00 |
Robinson James A. Jr. |